## Abstract In this study, the long‐term (>3 years) efficacy of combination therapy for hepatitis B virus (HBV) recurrence and the associated factors were investigated. One hundred and sixty‐five consecutive HBsAg‐positive patients (92 with liver cirrhosis, 73 with hepatocellular carcinoma; HCC) wh
Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: A pilot study
✍ Scribed by Krüger, Martin ;Tillmann, Hans Ludger ;Trautwein, Christian ;Bode, Ulrike ;Oldhafer, Karl ;Maschek, Hansjörg ;Böker, Klaus H. W. ;Broelsch, Christoph E. ;Pichlmayr, Rudolf ;Manns, Michael P.
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 1996
- Tongue
- English
- Weight
- 831 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1074-3022
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Chronic hepatitis B virus (HBV) infection is a common cause of advanced liver disease and hepatocellular carcinoma and has become a worldwide public health issue. Liver transplantation (LT) is the most effective therapeutic option for HBV-infected patients who have acute or chronic liver failure and
Orthotopic liver transplantation in patients with hepatitis B-related cirrhosis is commonly complicated by reinfection with the hepatitis B virus, with rapidly progressive liver disease and poor survival rate. We assessed the efficacy of prior therapy with recombinant interferon-a on the prevention
## Identification of the hepatitis C virus-the main cause of posttransfusion and sporadic non -A, non-B hepatitisand the development of a diagnostic serological test have allowed us to study possible recurrence of this type of hepatitis after liver transplantation. Six of 34 consecutive transplant
1. Early recurrence of hepatitis C is universal. 2. Typical histopathologic features of hepatitis C virus (HCV) and acute allograft rejection (AAR) exist. 3. Early recurrent HCV may be differentiated from AAR. 4. Liver biopsy plays a role in diagnosing HCV and AAR. 5. Risk factors for recurrent HCV
From the 1 Division of Liver Transplantation and the 2 Division of Pathology, Mayo Clinic lents/mL (geq/mL) as the lowest level of detection. 7